Determinants of quality of life and pulmonary function decline in Pseudomonas aeruginosa-colonised bronchiectasis: a longitudinal study
Pseudomonas aeruginosa (PA) colonisation is a key prognostic factor in non-cystic fibrosis bronchiectasis (BE), associated with pulmonary exacerbations (PE), lung function decline, and poorer health-related quality of life (HRQoL). We aimed to identify clinical and microbiological determinants of HRQoL and pulmonary function decline over one year in PA-colonised BE. We followed sixty-eight PA-colonised BE adults assessing HRQoL (QoL-B v3.1) and spirometry quarterly. Linear mixed-effects models and logistic regression examined body mass index (BMI), colonisation status, PA sputum phenotype, frequency of PE/previous year, and pulmonary function phenotype. Lower BMI was associated with early decline across Physical (β 1.52 [0.69], p = 0.029), Health Perceptions (1.67 [0.59], p = 0.005), and Respiratory Symptoms (1.26 [0.56], p = 0.025) HRQoL domains. Chronic colonisation contributed to early Physical (-17.58 [6.99], p = 0.013) and Social Function (-13.73 [5.86], p = 0.020) decline, while mucoid PA predicted early Physical Function worsening (-15.60 [6.53], p = 0.018). Non-obstructive BE was linked to six-month deterioration in Vitality (-17.17 [8.61], p = 0.047), Social Function (-21.02 [8.69], p = 0.017), and Respiratory Symptoms (-13.28 [6.00], p = 0.028). Mucoid PA and ≥1PE/year were the most consistent predictors of multidomain HRQoL deterioration. These determinants were also associated with forced expiratory volume in one second (FEV₁)/forced vital capacity (FVC) decline. These findings identify factors associated with deterioration in PA-colonised BE, which may inform closer clinical follow-up.
Authors
- Rubén López-Aladid (ORCID: https://orcid.org/0000-0002-4976-6571)
- Leticia Bueno (ORCID: https://orcid.org/0000-0002-2392-8763)
- Giulia Scioscia (ORCID: https://orcid.org/0000-0002-2667-077X)
- Néstor Soler (ORCID: https://orcid.org/0000-0003-4371-3994)
- Laia Fernández‐Barat (ORCID: https://orcid.org/0000-0001-7528-9636)
- Roberto Cabrera (ORCID: https://orcid.org/0000-0002-5797-9040)
- Victoria Alcaraz-Serrano (ORCID: https://orcid.org/0000-0001-6036-9545)
- Antoni Torres (ORCID: https://orcid.org/0000-0002-5649-7699)
- Alexandre López-Gavín
- Nil Vázquez
- Albert Gabarrús
- Miquel Ferrer
- Adrián Ceccato
- Patricia Oscanoa-Huamán
Institutions
- University of Foggia (IT)
- Instituto de Salud Carlos III (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Clínic de Barcelona (ES)
- Corporació Sanitària Parc Taulí (ES)
- Institute of Research and Innovation Parc Tauli (ES)
- Barcelona Institute for Global Health (ES)
- Fundació Clínic per a la Recerca Biomèdica (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (ES)
- Universitat Ramon Llull (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1038/s41598-026-79910-3
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Generalitat de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
- Sociedad Española de Neumología y Cirugía Torácica
- Instituto de Salud Carlos III